Alterations in GSK-3/Wnt Signaling in Olfactory Neuroepithelial Cells and Postmortem Brains of Bipolar Disorder Patients

被引：0
|
作者：
Ray, Rabindranath [1 ]
Barrett, Marna [1 ]
Thase, Michael [1 ]
Mizra, Natasha [2 ]
Borgmann-Winter, Karin [1 ]
Hahn, Chang-Gyu [1 ]
机构：
[1] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Otorhynolaryngol, Philadelphia, PA 19104 USA
来源：
BIOLOGICAL PSYCHIATRY | 2014年 / 75卷 / 09期
关键词：
GSK-3; Wnt; bipolar disorder; Lithium; post-mortem;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
548
引用
下载
收藏
页码：151S / 151S
页数：1
相关论文
共 50 条
  • [1] GSK-3 and Wnt signaling in neurogenesis and bipolar disorder
    Valvezan, Alexander J.
    Klein, Peter S.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2012, 5
  • [2] Gene expression alterations in bipolar disorder postmortem brains
    Chen, Haiming
    Wang, Nulang
    Zhao, Xin
    Ross, Christopher A.
    O'Shea, K. Sue
    McInnis, Melvin G.
    BIPOLAR DISORDERS, 2013, 15 (02) : 177 - 187
  • [3] Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications
    Muneer, Ather
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2017, 15 (02) : 100 - 114
  • [4] Cell cycle alterations in olfactory neuroepithelial cultures from adults with schizophrenia and bipolar disorder
    McCurdy, RD
    Perry, C
    Féron, F
    McClean, D
    Mackay-Sim, A
    McGrath, JJ
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 62 - 62
  • [5] Evaluation of the Association between Lithium Treatment and GSK-3β Polymorphism in Bipolar Disorder Patients
    Altinbas, Kursat
    Yesilbas, Dilek
    Ince, Bahri
    Cansiz, Alparslan
    Silan, Fatma
    Ozdemir, Ozturk
    Guloksuz, Sinan
    TURK PSIKIYATRI DERGISI, 2018, 29 (02) : 73 - 78
  • [6] Premise and peril of Wnt signaling activation through GSK-3β inhibition
    Law, Samuel M.
    Zheng, Jie J.
    ISCIENCE, 2022, 25 (04)
  • [7] GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
    Rowe, Michael K.
    Wiest, Charlotte
    Chuang, De-Maw
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (06): : 920 - 931
  • [8] Wnt-GSK-3/beta-catenin signaling as a target in the treatment of schizophrenia and bipolar disorder
    Karmacharya, Rakesh
    Cheng, Chialin
    Cohen, Bruce M.
    Haggarty, Stephen J.
    Schreiber, Stuart L.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 104S - 104S
  • [9] Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients
    Kozlovsky, N
    Belmaker, RH
    Agam, G
    AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (05): : 831 - 833
  • [10] GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients
    Nadri, C
    Dean, B
    Scarr, E
    Agam, G
    SCHIZOPHRENIA RESEARCH, 2004, 71 (2-3) : 377 - 382
12345